Company intelligence / Profile preview

Cambio

Dry Drayton, England, United Kingdomcmbio.io ↗

Ownership: Private
Development stage: Commercial

Overview

Cambio is an established supplier of advanced molecular biology reagents and consumables to research laboratories in academia, pharma, biotech, government agencies, agriculture, and environmental sectors. They are known for distributing innovative tools that accelerate scientific discovery but do not themselves conduct clinical trials or have proprietary therapeutic programs.

Modalities: Small molecule screeningProtein assaysNucleic acid manipulation
Industry: Chemicals & Materials

Partnerships

Distributor partnerships with global manufacturers such as BellBrook Labs for Transcreener® HTS Assays and iuvo Microconduit Arrays

Beyond the preview

Go deeper on Cambio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cambio.

Explore the full profile